Trial of a blood product for heparin resistance during heart surgery
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests a blood-derived medicine (antithrombin) to help people who do not respond well to the blood thinner heparin during heart surgery. It aims to make surgery safer by improving blood thinning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for heart surgery that uses a heart-lung machine.
- You have a condition called heparin resistance (your blood does not thin enough with a high dose of heparin).
- You are between 18 and 85 years old.
- You can provide written or electronic consent to join the study.
- If you can become pregnant, you must have a negative pregnancy test within 2 weeks before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a protein called antithrombin can predict how well a blood thinner called heparin will work during heart surgery. Understanding this connection may help doctors better manage blood clotting during your operation.
This trial compares two blood thinners (bivalirudin and heparin) during a procedure to open blocked heart arteries (PCI) in patients with a recent heart attack or unstable angina who also have a high risk of bleeding. The goal is to see which drug works better and is safer for patients like you.
This study looks at whether genetic and blood test information can help manage heparin-induced thrombocytopenia (HIT), a condition where blood platelets drop after heparin use. If you’ve been evaluated for HIT and received certain heparin medicines, your results may help researchers choose safer, more personalized care.
This study compares the best way to give blood thinners around certain heart procedures (TEER or left atrial appendage closure). It aims to lower the risk of dangerous clots and bleeding during and after the procedure.
This trial studies the best way to manage blood thinning (anticoagulation) during heart surgery that uses a heart-lung machine in people with obesity. It may help reduce blood-clotting and bleeding complications by comparing different care strategies.
This trial tests whether giving heparin (a blood thinner) during a specific type of heart procedure is safer and works better than not giving it. It focuses on patients where the blood supply in the hand’s artery connection is functioning properly.
Hear when a new Acquired Antithrombin Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.